Revenue and earnings are both falling — a 1-of-4 Financial Scorecard, with earnings down 46% year over year — yet 68.66% of 20 analysts rate Exxon Buy, with an average target of $165.11, about 10% above the price. The P/E reads 25x only because profits sit at a cyclical low. Current price: $150.64.
Changes over time: 1 discontinued (technology licensing revenues, which fell from $155M in 2023 to $102M in 2024 before being dropped), 2 New & Sustained, 2 Evolved, 2 New Products — a portfolio shifting toward lower-emission energy and specialty petrochemical products.
Exxon Mobil operates across the full energy value chain — upstream exploration and production, downstream refining, and chemicals — giving it scale few competitors can match. Its strategic emphasis is shifting toward lower-emission businesses such as carbon capture, hydrogen, and ammonia, alongside petrochemical manufacturing, areas the company is positioning for long-term demand as the energy transition unfolds.
Exxon Mobil's value rests on a fortress balance sheet and disciplined capital allocation through a cyclical commodity business. Debt is low relative to equity and coverage is comfortable, which lets the company sustain its dividend and reinvest through down-cycles. Profitability swings with oil and gas prices: trailing revenue of $326 billion currently converts to a thin 7.8% net margin and a 9.9% return on equity, both well below the company's mid-cycle potential.
Y = price target. X = days remaining on call (negative = past expected hit window). Bubble size = Anachart Performance Score. Dashed vertical = the expected-hit boundary.
Chart shows 5 of 20 covering analysts. See all on Anachart →
Exxon Mobil's scorecard reads weak, and the underlying numbers explain why. Annual revenue fell about 4.5% and earnings dropped 46% year over year, dragging the net margin to 7.8% and return on equity to 9.9% — both well below what the company earns at mid-cycle oil and gas prices. restnvest captures that down-year directly: Growth Quality is Declining, and only the balance sheet, with comfortable debt coverage, is rated strong. The important context is that this is a cyclical trough, not structural decline. The same low earnings that pull the scorecard down also push the P/E up to 25x, which looks expensive but reflects depressed profits rather than a rich valuation. Analysts read the cycle more than the snapshot: 68.66% rate the stock Buy, with an average target of $165.11 against a price near $151 — roughly 10% upside — and a 96% historical hit ratio, the highest of any ticker in this set. The stock trades 14% below its 52-week high but above its 200-day average, which restnvest scores as Neutral Entry, and timing is 0 of 3 supportive, so the near-term backdrop is unsettled. The reconciliation is a disagreement about time horizon: restnvest's scorecard describes the business as it is reporting today, while the analyst consensus and the dividend-oriented market price a well-capitalized major positioned for the next up-cycle.
Dive deeper into the fundamentals
See Exxon Mobil's full 6-stage analysis on restnvest →See the full analyst picture
See all 20 analyst price targets on Anachart →